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Abstract
Background: Alcohol harms are rising globally, and alcohol policies, where they exist, are weak or under-
developed. Limited progress has been made since the formulation of the World Health Organisation (WHO) Global
Strategy in 2010. WHO is seeking to accelerate progress in implementing international efforts to reduce the harmful
use of alcohol. The threat to global health posed by tobacco is well understood by policy communities and
populations globally; by contrast alcohol is much less so, despite available evidence.
The competition for epistemic authority: Global alcohol corporations have sought to become trusted sources of
advice for policy makers and consumers, while continuing to grow their markets. Evidence-informed public health
messaging faces formidable competition from transnational corporations as the worlds of corporate and political
communications, social and mainstream media become increasingly linked, presenting new opportunities for
corporate actors to shape global health governance. Alcohol messaging that uses means of persuasion tied to
industry agendas does not tell a clear story about commercial determinants of health, and does not contribute to
health improvement. On the contrary, the basic tenets of an evidence-informed population-based approach are
denied and the policy measures supported by high quality evidence are being opposed, because they are inimical
to commercial interests. A David and Goliath metaphor for this state of affairs, which seems to fit at first glance,
may unwittingly reinforce the status quo.
Conclusion: Public opinion on alcohol and policy issues varies across time and place and can be influenced by
dedicated public health interventions. Alcohol marketing dominates people’s thinking about alcohol because we
currently allow this to happen. Greater ambition is needed in developing countermarketing and other interventions
to promote evidence-informed ideas with the public. Alcohol policies need to be further developed, and
implemented more widely, in order to arrest the growing burden of alcohol harms across the world.
Keywords: Commercial determinants of health, Alcohol, Public health, Alcohol marketing, Alcohol industry, Alcohol
policy, Global health
Background
Alcohol policies, where they exist, are usually weak or
under-developed in the face of the challenges with which
they contend [1]. The current global annual death toll of
3 million is forecast to rise, particularly in low and mid-
dle income countries [2]. A minority of the world’s
population drinks alcohol, so there is a large market to
be developed [1]. A small number of corporations now
produce most of the beer and spirits consumed across
the world, creating an oligopoly [3]. Building consumer
relationships with distinctive brands, creatively tailored
to appeal to targeted audiences, helps provide competi-
tive edge for individual companies [4]. This also conveys
a sense of proliferating choice, even when innovations in
production are absent. The worlds of corporate and
political communications, social and mainstream media
have become increasingly linked, presenting new
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opportunities for corporate actors to shape global health
governance [5]. Extensive resources are deployed to ex-
ploit these opportunities and close relationships are built
with key political actors through lobbying [6]. It is a
marketing truism that those who set the frame control
the agenda [7].
Evidence-informed public health messaging thus faces
formidable competition from transnational alcohol cor-
porations. This resembles in part a contest over epi-
stemic authority, as corporations seek to become trusted
sources of advice for policy makers and consumers,
while continuing to grow their markets [8]. There is a
growing mismatch between the expansion of global mar-
kets and efforts at national regulation [9]. A World
Health Organisation (WHO) Action plan (2022–2030) is
now proposed to accelerate progress in implementing
international efforts to reduce the harmful use of alcohol
[10]. This is needed because of the limited progress
made since the formulation of a Global Strategy in 2010
[11, 12]. It can sometimes seem to public health interests
that they are David, daring to hope to win against the
odds, and the corporation is Goliath. Given that the ac-
tions that need to be taken are largely well established in
the alcohol policy evidence, David should be winning by
now. To get off the back foot, we need to further de-
velop our understanding of the changing nature of the
challenge.
The competition for epistemic authority
No level playing field
Corporate communication campaigns are now not only
about introducing and seeking views on particular prod-
ucts and brands, but leading opinion more broadly in
market friendly directions [13]. Corporate communica-
tors take a strategic approach to the identification and
segmentation of publics, cultivating relationships to in-
fluence consumer and public opinion and promoting
reasons to care about brands and industry interests [14].
Because of the harmful nature of their products, alcohol
producers are deeply invested in branding themselves as
good corporate citizens [15, 16]. Corporate social re-
sponsibility initiatives like Drinkaware in the UK work
as a form of implicit alcohol industry branding, man-
aging conflicts between corporate and public health in-
terests [17–20]. Such initiatives are produced within a
corporate market logic focused on sustaining profit
growth which indirectly promotes product consumption
as responsible and normal [19, 21].
As well as publishing misinformation for the public
[22, 23], the alcohol industry also funds and publishes
research which casts doubt on scientific evidence about
product harms and policy responses, some of which is
designed to emphasise purported benefits [24–26]. The
basic tenets of an evidence-informed population-based
approach are denied and the policy measures supported
by high quality evidence are opposed, because they are
inimical to commercial interests [27, 28]. Extensive pol-
itical lobbying and stakeholder marketing has created
key networks and partnerships in many countries and,
together with free market think tanks, provided persua-
sive rationales to secure preferred policy directions [8,
29]. The power imbalance raises important market ethics
issues [30], as well as obvious public health policy issues.
Corporate investment in shaping drinking norms and
distracting from evidence on alcohol harms amounts to
the cultivation of ignorance, as pioneered by the tobacco
industry [31, 32]. The tobacco playbook has been
adopted by other industries [33], and there are deep his-
torical links between alcohol and tobacco companies
[34, 35]. There is recent evidence of tobacco and alcohol
collaborative efforts to undercut the credibility of science
[36] and they have long sought to influence policy to-
gether [37]. This helps to explain why alcohol has been
appositely described as a global health blind spot [38].
Alcohol exceptionalism
The threat to global health posed by tobacco is well
understood; alcohol much less so, despite a substantial
epidemiological evidence base identifying it as a major
contributor to the global burden of disease, disability
and death [39]. The alcohol and tobacco industries de-
pend on addiction and other harmful forms of consump-
tion in their operating models, and make products that
harm others as well as the individual consumer [40, 41].
‘Tobacco exceptionalism’ refers to the ways we think of
the tobacco industry and its products as uniquely dan-
gerous, and in need of a unique model of governance
[42]. Thinking about the alcohol industry in such ‘excep-
tional’ terms seems harder to grasp. The promotion of
alcohol is widespread, yet the industry that produces it
appears invisible, with product retail largely undertaken
by other parties such as the ‘hospitality industry’ and su-
permarkets. The alcohol and tobacco industries are both
responsible for non-communicable diseases [43], with al-
cohol also implicated in infectious diseases [44]. Both
products cause multiple health harms including cancers,
cardiovascular diseases and foetal damage. Alcohol add-
itionally causes overdose, intoxication, violence, suicide,
accidents, job loss, sexually transmitted infections, unin-
tended pregnancy and family breakdown. As with smok-
ing, many of the health harming impacts of drinking are
cumulative, manifesting over the longer term, and like
COVID-19, its impacts fall heaviest in socioeconomically
disadvantaged communities [11]. Alcohol can also kill
quickly [45].
A long tradition of drinking in some societies may ac-
count for an implicit acceptance, and the normalisation
of alcohol harms, which may lead to a view that change
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is not possible. There is limited research on people’s per-
ceptions of their own drinking and most of this is con-
ducted with young people [46]. In such studies, as with
the reinforcing effects of corporate social responsibility
organisation messaging, personal risk is perceived as low
[47]. A particular stereotypical and stigmatising view of
the ‘alcoholic’ as ‘other’ serves to distance adult drinkers
from recognition of risk or harm, regardless of their
current health status or the quantity of alcohol actually
consumed [48].
Reducing alcohol health harms inevitably means redu-
cing the amount of the drug ethanol consumed, as this
is the source of the harm [49]. Just as with tobacco, the
most effective and cost-effective interventions are in-
creasing the price of alcohol and reducing its physical
availability and marketing [50]. Yet, alcohol remains a
privileged, protected, and indeed ubiquitous product.
The contrast with tobacco is increasingly stark. Alcohol
has been defined as an ‘essential’ commodity in the UK
and Australia during the COVID-19 pandemic, with off-
sales protected and pubs the first places to open up as
lockdowns eased [51–53]. Alcohol industry actors are
exceptionally effective at distracting attention from re-
sponsibility for harm, the extent of policy interference,
and the similarities with tobacco.
Taking alcohol messaging upstream
There is gross asymmetry in the resources available
in the research and public health arenas to produce,
test and distribute high quality, well targeted, public-
focused, messaging tailored for a range of media. It
does look like something of a David and Goliath con-
test to oppose the interests of major transnational
corporations and to intervene in an enjoyable well
established social practice for many. Responsibility for
the choice to drink rests with the individual, and
somewhat less attention gets paid to the nature of the
market, the information conditions under which that
choice is exercised, and other constraints on individ-
ual choice. There are other asymmetries in play. The
costs are borne by society, with the risks operating at
individual, family, community and population levels,
whilst corporations and their shareholders enjoy the
benefits. Not drinking, or drinking less alcohol, can
feel like opting out of an activity considered by others
as central to relaxing and having fun.
The impoverished nature of public discourse on alco-
hol harms, means this is not an area where the public
are currently clamouring to see more intervention. Mar-
keting thus proceeds to lock in branded thinking about
alcohol, in a vicious circle. Public opinion on alcohol
and policy issues varies across time and place and can be
influenced by public health interventions [54]. Existing
evidence on mass media interventions is weak, and these
are under-developed [55]. The ambition needed must
match the sophistication of alcohol marketing in order
to counter it. More needs to be done to understand how
to get evidence-informed ideas out to the public and to
create demand for population health measures.
Our work has identified the caution, scepticism and
confusion with which ordinary drinkers receive advice
from health professionals and the discomfort that health
professionals experience in discussing drinking [56–58].
Even for those convinced that their drinking is not a
‘problem,’ being asked about alcohol use in a health con-
text can elicit negative emotions, including feeling
judged or guilty, making open conversation difficult. In
such circumstances a brief chat will rarely be any match
for the huge corporate investment in encouraging drink-
ing, and the wider and long running shaping of how we
think about alcohol.
Corporate messaging has long experimented with ac-
tive persuasion; shaping preferences to match values or
solve problems. Messengers use a range of strategies to
obtain favourable policy environments, build constituen-
cies, sow doubt, creatively pursue “defactualization” tak-
ing advantage of what the audience wants to hear, with a
careful eye to making this all credible and coherent [59].
Opportunities for attracting attention and practicing
persuasion have expanded with the rise of digital social
media, giving rise to formidable persuasion industries
[60]. Some countries provide financial incentives for al-
cohol industry marketing through their taxation policies.
For example, in the US, in 2017 the top 10 alcohol pro-
ducers were exempted from paying taxes on US $1.5 bil-
lion for beer advertising alone [61]. Marketing to
consumers is far from only being about persuading
people to make purchase decisions, but analysing cus-
tomers’ choices and behaviours so they are not even
aware their buying decisions are being scrutinised and
influenced [62]. Data analytics underpin what has been
understood as surveillance capitalism [63, 64]. Social
media offers publishing platforms funded by data-driven
advertising which are free of the regulations to which
other forms of media are subject, with no responsibility
for accuracy of content.
Alcohol messaging must contend with how alcohol
and alcohol harm can be reframed to evoke a different
way of thinking about the personal and policy choices
for health to be improved. This requires countermarket-
ing that addresses ideas that products are new, aspir-
ational, and identity, socially or even health enhancing.
Learning from the tobacco experience makes many les-
sons available on how to make progress in improving
population health [38, 65]. The nature of the threat to
global health means that the situation will get worse un-
less we embrace the many challenges posed by alcohol
marketing.
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Alcohol research has historically been predominantly
focused on particular populations and forms of proble-
matized drinking that have stereotypical and highly stig-
matised and stigmatising foundations [66, 67]. Alcohol
science has been built around the fundamentally flawed
concept of alcoholism and the associated treatment
movement, in part due to industry involvement since
the 1940s [68]. Similarly, alcohol health messaging is
currently framed in an extreme close up on the drinker
and whether or not they are consuming responsibly [69,
70]. The appearance of placing limits on individual
choices is seized on by industry messaging, which add-
itionally stereotypes the meddling, moralising ‘expert’
and nanny telling people what to do. We could begin to
develop the science of alcohol messaging simply by
introducing a wider angle which includes the corporate
context and the drug ethanol as characters within the
messaging.
Conclusion
Gerard Hastings wrote a key textbook on social mar-
keting subtitled “why should the devil get all the best
tunes?” [71] This rhetorical question invites us to in-
vest more substantially in countermarketing ideas in
improving health. Corporate actors, particularly in
controversial sectors which damage health or the en-
vironment, are adept at myth making [72]. The alco-
hol companies, and the neoliberal fictions they
contribute to and benefit from, position the state as
Goliath, and the individual consumer as David. They
use sophisticated tools of persuasion to ally them-
selves with David, producing a dystopian version of
individual freedom which allocates responsibility for
risk to individuals and renders invisible the processes
of maximising shareholder wealth.
So many of the contemporary challenges in public
health revolve around such contests with powerful
global corporations, and alcohol is no different. The
David and Goliath story has undergone many revi-
sions in its re-telling to become a powerful metaphor
for the potential of the plucky underdog. This meta-
phor is unhelpful if it keeps public health David on
the back foot and stuck at the start of the contest.
Alcohol marketing dominates people’s thinking about
alcohol because we currently allow this to happen.
We give corporations a license to operate, and we
should look at the terms of the license, and revise
them, to better protect public health. Some countries
have complete bans on alcohol marketing and WHO
recommends that such bans should be enforced
where they exist, and comprehensive restrictions on
advertising, sponsorship and promotion introduced
where they do not. If that idea makes you uncomfort-
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